In vivo selection of moxifloxacin-resistant Clostridium difficile

Antimicrob Agents Chemother. 2012 May;56(5):2788-9. doi: 10.1128/AAC.06433-11. Epub 2012 Feb 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Aza Compounds / therapeutic use*
  • Clostridioides difficile / drug effects
  • Clostridioides difficile / genetics*
  • Clostridioides difficile / isolation & purification
  • DNA Gyrase / genetics*
  • Drug Resistance, Bacterial / genetics*
  • Enterocolitis, Pseudomembranous / drug therapy*
  • Enterocolitis, Pseudomembranous / microbiology
  • Fluoroquinolones
  • Humans
  • Isoenzymes / genetics
  • Male
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Mutation
  • Quinolines / therapeutic use*
  • Sequence Analysis, DNA

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Isoenzymes
  • Quinolines
  • DNA Gyrase
  • Moxifloxacin